CCR1-mediated monocyte chemotaxis in the immunopathology of primary Sjögren’s syndrome: multi-omics integration analysis and computational target prioritization implicating Polygonatum odoratum - Scorecard - MDSpire
Advertisement
Investigating CCR1's Role in Monocyte Migration within the Immunopathology of Primary Sjögren’s Syndrome: A Multi-Omics Approach and Computational Analysis Highlighting Polygonatum odoratum as a Potential Therapeutic Target
Clinical Scorecard: Investigating CCR1's Role in Monocyte Migration within the Immunopathology of Primary Sjögren’s Syndrome: A Multi-Omics Approach and Computational Analysis Highlighting Polygonatum odoratum as a Potential Therapeutic Target
At a Glance
Category
Detail
Condition
Primary Sjögren’s syndrome
Key Mechanisms
CCR1 upregulation in monocytes, CCL5–CCR1-mediated monocyte chemotactic recruitment
Target Population
Patients with primary Sjögren’s syndrome
Care Setting
Immunopathology research and therapeutic target exploration
Key Highlights
CCR1 is significantly upregulated in pSS patients and correlates with serum IgG levels.
Single-cell analysis shows CCR1 is highly expressed in classical monocytes in pSS.
Moupinamide from Polygonatum odoratum shows predicted binding affinity to CCR1.
The study integrates transcriptomics, network pharmacology, and single-cell sequencing.
pSS treatment currently lacks targeted therapies addressing underlying etiology.
Guideline-Based Recommendations
Diagnosis
Utilize transcriptomic datasets and clinical validation for diagnosing pSS.
Management
Consider CCR1 as a potential therapeutic target in pSS treatment strategies.
Monitoring & Follow-up
Monitor CCR1 expression levels and associated immune markers in pSS patients.
Risks
pSS patients have a significantly increased risk of developing non-Hodgkin lymphoma.
Patient & Prescribing Data
Patients diagnosed with primary Sjögren’s syndrome.
Polygonatum odoratum may offer therapeutic benefits through CCR1 modulation.
Clinical Best Practices
Incorporate multi-omics approaches in understanding autoimmune disease mechanisms.
Validate computational findings with experimental studies in clinical samples.
